rs397517675
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_001267550.2(TTN):c.68272G>A(p.Asp22758Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000136 in 1,611,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.68272G>A | p.Asp22758Asn | missense_variant | Exon 321 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.68272G>A | p.Asp22758Asn | missense_variant | Exon 321 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152018Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000203 AC: 5AN: 246774Hom.: 0 AF XY: 0.0000374 AC XY: 5AN XY: 133808
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1459864Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 726132
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152018Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74240
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Asp20190Asn variant (TTN) has not been reported in the literature nor previo usly identified by our laboratory. It was absent from >3,000 European American individuals sequenced by the NHLBI exome sequencing project (http://evs.gs.washi ngton.edu/EVS). This low frequency is consistent with a disease causing role but insufficient to establish this with confidence. Computational analyses (biochem ical amino acid properties, conservation, PolyPhen2, and SIFT) suggest that this variant may impact the protein, though this information is not predictive enoug h to determine pathogenicity. In summary, additional information is needed to fu lly assess the clinical significance of the Asp20190Asn variant. -
not provided Uncertain:1
A variant of uncertain significance has been identified in the TTN gene. The D21117N variant, also denoted as D20190N due to the use of an alternate transcript, has been reported in a 16 year-old Caucasian male with a clinical diagnosis of DCM, no skeletal myopathy, and no family history of DCM (Pugh et al., 2014); however, this individual harbored additional cardiogenetic variants and no segregation studies were described. Nevertheless, the D21117N variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The D21117N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. Furthermore, this substitution occurs at a position where only amino acids with similar properties to Aspartic acid are tolerated across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. However, although D21117N is located in the A-band region of titin, the majority of pathogenic variants in the TTN gene associated with DCM are truncating variants in the A-band region of titin (Herman et al., 2012). Additionally, this variant is also classified as a variant of uncertain significance in ClinVar by another clinical laboratory (ClinVar SCV000064225.4; Landrum et al., 2016). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at